Evidence map›Paper›PMID 39763595›Full record

ArticleEClinicalMedicine2024

Syphilis infection prevalence in the Middle East and North Africa: a systematic review and meta-analysis.

Mariam El-Jamal, Beyhan Annan, Alaa Al Tawil, Melissa Hamati, Sawsan Almukdad, Iman Fakih, Fatema Dabdoub, Eman Sharara, Muhammad S Jamil, Ahmed S Alaama and 4 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Epidemiology ofBMJ global health · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mariam El-JamalDepartment of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.
Beyhan AnnanDepartment of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.
Alaa Al TawilDepartment of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.
Melissa HamatiDepartment of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.
Sawsan AlmukdadInterprofessional Education Office, QU Health, Qatar University, Doha, Qatar.
Iman FakihDepartment of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.
Fatema DabdoubDepartment of Family and Community Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Eman ShararaDepartment of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.
Muhammad S JamilDepartment of Communicable Diseases, HIV/Hepatitis/STIs Unit, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Ahmed S AlaamaDepartment of Communicable Diseases, HIV/Hepatitis/STIs Unit, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Joumana G HermezDepartment of Communicable Diseases, HIV/Hepatitis/STIs Unit, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Jane RowleyDepartment of Global HIV, Hepatitis, and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
Laith J Abu-RaddadInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
Ghina R MumtazDepartment of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Syphilis is a sexually transmitted infection (STI) that can be prevented and effectively treated; yet it continues to be a cause of morbidity and mortality worldwide. There is a limited understanding of the epidemiology of syphilis in the Middle East and North Africa (MENA) region. Methods: A systematic review conducted up to April 30, 2024 assessed the prevalence of syphilis and followed PRISMA guidelines, without language and date restrictions. Syphilis infection was categorized based on the diagnostic test type, distinguishing between current and lifetime infections. Pooled mean prevalence estimates were determined through random-effects meta-analyses. Random-effects meta-regression analyses were conducted to investigate sources of heterogeneity between studies and identify factors associated with syphilis prevalence. Findings: The review identified 643 studies based on close to 38 million syphilis tests in the 24 MENA countries. The pooled prevalence for probable current syphilis infection was 0.004% (95% CI: 0.001%-0.025%) among blood donors, 0.48% (95% CI: 0.22%-0.82%) in the general population (pregnant women and other general population groups), 2.76% (95% CI: 1.51%-4.35%) in populations at intermediate risk, 4.18% (95% CI: 2.08%-6.89%) among STI clinic attendees, 12.58% (95% CI: 8.45%-17.35%) among female sex workers, and 22.52% (95% CI: 12.73%-34.06%) among men who have sex with men and transgender people. Meta-regression analyses explained 62% of the prevalence variation and indicated a hierarchical pattern in prevalence by population group, higher prevalence among men, considerable subregional variability, and an annual decline of 3% in prevalence among general population groups and 8% among populations at high risk. Interpretation: Syphilis prevalence in MENA is comparable to global levels, emphasizing a considerable yet often overlooked disease burden with implications for reproductive health and social well-being. The observed rate of decline in syphilis prevalence and the current response fall short of the global targets. Action is required to control syphilis and mitigate its impact, especially in most affected populations. Funding: Qatar Research, Development, and Innovation Council (ARG01-0524-230273); Qatar National Research Fund (NPRP grant number 9-040-3-008).

Indexed as

Middle East and North AfricaPrevalenceSyphilisTreponema pallidum

Identifiers

PMID39763595
PMCPMC11701444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.